Skip to main content

Table 1 Data inputs used in the model

From: Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods

 

Mean

SE

Distribution

Source

Treatment decision probabilities

 MT, FFR

0.23

0.03

Dirichlet

FAMOUS

 PCI, FFR

0.71

0.02

Dirichlet

FAMOUS

 CABG, FFR

0.06

0.02

Dirichlet

FAMOUS

 MT, standard care

0.13

0.02

Dirichlet

FAMOUS

 PCI, standard care

0.80

0.01

Dirichlet

FAMOUS

 CABG, standard care

0.07

0.02

Dirichlet

FAMOUS

Equipment costs (£):

 Guiding catheter

20

0

National procurement

 Guidewire

20

0

National procurement

 Pressure wire

270

0

National procurement

 Adenosine vial

12

0

BNF

 Balloon catheter

50

0

National procurement

 Drug eluting stent

290

0

National procurement

 Bare metal stent

90

0

National procurement

 Tirofiban (avg/patient)

242

69

Gamma

BNF; evidence.nhs.uk

 Bivalirudin (avg/patient)

625

48

Gamma

BNF; evidence.nhs.uk

 Clopidogrel (per month)

2

 

BNF; evidence.nhs.uk

Procedure costs (£):

 CABG

5041

313

Gamma

NHS reference costs

 Echocardiogram

128

26

Gamma

Golden Jubilee National Hospital

 Optical coherence tomography

1020

204

Gamma

Golden Jubilee National Hospital

 Intravascular ultrasound

540

108

Gamma

Golden Jubilee National Hospital

 Chest x-ray

18

4

Gamma

Golden Jubilee National Hospital

Hospitalisation costs (£):

 Cath lab time (per hour)

1681

301

Gamma

ISD Scotland

 Day in CCU

1492

60

Gamma

Golden Jubilee National Hospital

 Day in ITU

2288

458

Gamma

Golden Jubilee National Hospital

 Day in general ward

303

17

Gamma

NHS reference costs

Inhospital event costs (£):

 Severe bleeding

222

3

Gamma

NHS reference costs

 Stroke

2709

129

Gamma

NHS reference costs

 MI

1492

76

Gamma

NHS reference costs

Event costs (£):

 Rehospitalisation

2261

452

Gamma

NICE CG94

 Revascularisation

2477

63

Gamma

NHS reference costs

 MI

2261

452

Gamma

NICE CG94

Disease related costs (index year) (£):

 Index year after additional MI

3228

215

Gamma

NICE CG94

 Index year of stroke

16,926

428

Gamma

NICE CG68

Additional life-expectancies (years)

 MACE

10.70

2.20

Normal

Kent et al., NICE CG94

 No MACE

5.96

1.30

Normal

Kent et al., NICE CG94

Other long-term parameters

 Annual cost post year 1 (£)

423

55

Gamma

Kent et al., NHS reference costs

 MACE utility change

−0.05

0.04

Beta

Kent et al., Palmer et al.